Cas:36529-70-1 Pyrimidine, 5-methoxy-, 1-oxide (9CI) manufacturer & supplier

Chemical Name:Pyrimidine, 5-methoxy-, 1-oxide (9CI)

CAS.NO:36529-70-1

Synonyms:5-Methoxypyrimidin;5-Methoxypyrimidin-1-oxid;5-methoxypyrimidine N-oxide;5-Methoxy-pyrimidin-N-oxid;5-methoxy-pyrimidine 1-oxide;5-methoxy pyrimidine;pyrimidine,5-methoxy

Molecular Formula:C₅H₆N₂O₂

Molecular Weight:126.11300

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:47.58000

Exact Mass:126.04300

LogP:0.51870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Methoxypyrimidin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pyrimidine,5-methoxy physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyrimidine,5-methoxy Use and application,5-methoxy-pyrimidine 1-oxide technical grade,usp/ep/jp grade.

Related News: If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. Pyrimidine, 5-methoxy-, 1-oxide (9CI) manufacturer At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. Pyrimidine, 5-methoxy-, 1-oxide (9CI) supplier But the ban from Italy remains, Joseph Wu, Taiwan��s foreign minister, said on Sunday. Pyrimidine, 5-methoxy-, 1-oxide (9CI) vendor If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. Pyrimidine, 5-methoxy-, 1-oxide (9CI) factory At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.